Bui TN - Search Results

1

Targeting Replicative Stress and DNA Repair by Combining PARP and Wee1 Kinase Inhibitors Is Synergistic in Triple Negative Breast Cancers with Cyclin E or BRCA1 Alteration.

Chen X, Yang D, Carey JPW, Karakas C, Albarracin C, Sahin AA, Arun BK, Guray Durak M, Li M, Kohansal M, Bui TN, Ha MJ, Hunt KK, Keyomarsi K. Chen X, et al. Among authors: bui tn. Cancers (Basel). 2021 Apr 1;13(7):1656. doi: 10.3390/cancers13071656. Cancers (Basel). 2021. PMID: 33916118 Free PMC article.

2

Overexpression of the low molecular weight cyclin E in transgenic mice induces metastatic mammary carcinomas through the disruption of the ARF-p53 pathway.

Akli S, Van Pelt CS, Bui T, Multani AS, Chang S, Johnson D, Tucker S, Keyomarsi K. Akli S, et al. Cancer Res. 2007 Aug 1;67(15):7212-22. doi: 10.1158/0008-5472.CAN-07-0599. Cancer Res. 2007. PMID: 17671189

3

Differential regulation of elafin in normal and tumor-derived mammary epithelial cells is mediated by CCAAT/enhancer binding protein beta.

Yokota T, Bui T, Liu Y, Yi M, Hunt KK, Keyomarsi K. Yokota T, et al. Cancer Res. 2007 Dec 1;67(23):11272-83. doi: 10.1158/0008-5472.CAN-07-2322. Cancer Res. 2007. PMID: 18056453

4

Low molecular weight cyclin E is specific in breast cancer and is associated with mechanisms of tumor progression.

Wingate H, Puskas A, Duong M, Bui T, Richardson D, Liu Y, Tucker SL, Van Pelt C, Meijer L, Hunt K, Keyomarsi K. Wingate H, et al. Cell Cycle. 2009 Apr 1;8(7):1062-8. doi: 10.4161/cc.8.7.8119. Epub 2009 Apr 10. Cell Cycle. 2009. PMID: 19305161 Free PMC article.

5

Post-translational modification and stability of low molecular weight cyclin E.

Mull BB, Cox J, Bui T, Keyomarsi K. Mull BB, et al. Oncogene. 2009 Sep 3;28(35):3167-76. doi: 10.1038/onc.2009.182. Epub 2009 Jun 29. Oncogene. 2009. PMID: 19561641

6

Low-molecular-weight cyclin E can bypass letrozole-induced G1 arrest in human breast cancer cells and tumors.

Akli S, Bui T, Wingate H, Biernacka A, Moulder S, Tucker SL, Hunt KK, Keyomarsi K. Akli S, et al. Clin Cancer Res. 2010 Feb 15;16(4):1179-90. doi: 10.1158/1078-0432.CCR-09-1787. Epub 2010 Feb 9. Clin Cancer Res. 2010. PMID: 20145171 Free PMC article.

7

Cyclin E deregulation impairs mitotic progression through premature activation of Cdc25C.

Bagheri-Yarmand R, Nanos-Webb A, Biernacka A, Bui T, Keyomarsi K. Bagheri-Yarmand R, et al. Cancer Res. 2010 Jun 15;70(12):5085-95. doi: 10.1158/0008-5472.CAN-09-4095. Epub 2010 Jun 8. Cancer Res. 2010. PMID: 20530684 Free PMC article.

8

Semi-high throughput method of measuring proteasome inhibition in vitro and in cultured cells.

Keyomarsi K, Efuet ET, Bui TN. Keyomarsi K, et al. Among authors: bui tn. Cell Biol Toxicol. 2011 Apr;27(2):123-31. doi: 10.1007/s10565-010-9175-1. Epub 2010 Sep 19. Cell Biol Toxicol. 2011. PMID: 20853140

9

Cdk2 is required for breast cancer mediated by the low-molecular-weight isoform of cyclin E.

Akli S, Van Pelt CS, Bui T, Meijer L, Keyomarsi K. Akli S, et al. Cancer Res. 2011 May 1;71(9):3377-86. doi: 10.1158/0008-5472.CAN-10-4086. Epub 2011 Mar 8. Cancer Res. 2011. PMID: 21385896 Free PMC article.

10

Staurosporine is chemoprotective by inducing G1 arrest in a Chk1- and pRb-dependent manner.

Murray MM, Bui T, Smith M, Bagheri-Yarmand R, Wingate H, Hunt KK, Keyomarsi K. Murray MM, et al. Carcinogenesis. 2013 Oct;34(10):2244-52. doi: 10.1093/carcin/bgt186. Epub 2013 May 30. Carcinogenesis. 2013. PMID: 23722650 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

72 results

Search Page

Filters